Found: 8
Select item for more details and to access through your institution.
Gene expression profiling identifies molecular subtypes of gliomas.
- Published in:
- 2006
- By:
- Publication type:
- Correction Notice
Molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies.
- Published in:
- Neuropathology & Applied Neurobiology, 2012, v. 38, n. 3, p. 271, doi. 10.1111/j.1365-2990.2011.01238.x
- By:
- Publication type:
- Article
P05.06 Phase 2 study to evaluate the safety, pharmacokinetics and clinical activity of PI3K/mTOR inhibitor GDC-0084 given to glioblastoma (GBM) patients with unmethylated O<sub>6</sub>-methylguanine-methyltransferase (MGMT) promoter status.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii35, doi. 10.1093/neuonc/noz126.120
- By:
- Publication type:
- Article
OS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii21, doi. 10.1093/neuonc/noz126.072
- By:
- Publication type:
- Article
PL3.1 A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in recurrent, IDH1-mutant, low-grade glioma: results from cohort 1.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii2, doi. 10.1093/neuonc/noz126.004
- By:
- Publication type:
- Article
P01.032 Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. iii235, doi. 10.1093/neuonc/noy139.074
- By:
- Publication type:
- Article
Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme.
- Published in:
- Advances in Therapy, 2011, v. 28, n. 4, p. 334, doi. 10.1007/s12325-011-0007-3
- By:
- Publication type:
- Article